Compare EVT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVT | INSP |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2003 | 2018 |
| Metric | EVT | INSP |
|---|---|---|
| Price | $28.16 | $69.08 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | 86.3K | ★ 863.2K |
| Earning Date | 01-01-0001 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $23.00 | $38.91 |
| 52 Week High | $29.65 | $147.03 |
| Indicator | EVT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 52.26 |
| Support Level | $27.59 | $68.13 |
| Resistance Level | $29.45 | $75.31 |
| Average True Range (ATR) | 0.43 | 3.25 |
| MACD | 0.00 | -0.88 |
| Stochastic Oscillator | 63.16 | 31.75 |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.